Bioresorbable stent passes clinical tests in Brazil


A bioresorbable polymer stent developed in the United States is reporting an important benchmark.

Reva Medical (San Diego, CA) says it has completed a clinical study of its ReZolve drug-eluting bioresorbable scaffold among 26 patients who reported no major adverse coronary events to date. The first patient in the study was enrolled in December 2011.

Principal Investigator Dr. Alexandre Abizaid of the Dante Pazzanese Instituto de Cardiologie in Sao Paulo, Brazil said: "We are very pleased to have implanted the current ReZolve scaffold in patients with no reported major adverse coronary events to date, and are eager to resume clinical trials with the ReZolve2 scaffold later this year."
Read more